Is Stryker (SYK) One of the Best Medical Technology Stocks to Buy Right Now Despite a Cyberattack?

Stryker Corporation (NYSE:SYK) is one of the best medical technology stocks to buy right now. On May 12, Argus analyst David Toung cut his price target on Stryker Corporation (NYSE:SYK) to $350 from $435 while keeping a Buy rating. This call followed a cyberattack that upended Stryker’s first quarter and sent its stock to a 52-week low.

Stryker suffered the cyberattack on March 11, which disrupted the company’s global information technology network. It resulted in client devices and servers becoming dysfunctional, and portions of the company’s operations ground to a halt.

Be that as it may, Stryker’s Q1 2026 results were robust; revenue grew 2.6% year over year to touch $6.02 billion, though it was lower than the $6.35 billion analysts expected. The EPS also came in lower at $2.60 against the expected $2.98, an 8.5% year over year decline.

The misses, however, did not dampen management’s optimism because they stuck with their full-year 2026 guidance. To Argus’s Toung, this was an important signal of the company’s resilience. He noted that Stryker’s strong underlying business execution and solid customer demand remained intact even as the near-term financial picture was distorted by the attack.

However, the analyst pointed out that the cyberattack damaged Stryker’s chances of achieving double-digit top-line revenue growth in 2026. His view was that Stryker could have easily managed that level of growth but the reputational and operational damage from the incident is just too much to ignore.

Stryker Corporation (NYSE:SYK) is a medical technology company that develops and manufactures products for orthopedics, medical and surgical equipment, and neurotechnology. Its portfolio includes joint replacement implants, trauma and spine devices, surgical navigation and robotic-assisted systems such as Mako.

READ NEXT: 7 Best Augmented Reality Penny Stocks to Buy and 10 Best Gene Therapy Stocks to Buy in 2026.

Disclosure: None. Follow Insider Monkey on Google News.